The University of Illinois System received Emergency Use Authorization from the U.S. Food and Drug Administration on Monday, March 1 for its saliva-based COVID-19 test, as the statewide seven-day rolling positivity rate reached 2.4 percent. The FDA approval allows for the covidSHIELD test to expand beyond the U of I System. The saliva-based COVID-19 test … Continue reading U of I receives FDA approval for saliva-based COVID-19 test